Broad Institute is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease
Propelling the understanding and treatment of disease
Collaborating deeply
Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world
Reaching globally
Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries
Empowering scientists
Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential
Building partnerships
Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer
Promoting inclusion
Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, and gender identity
INSIDE BROAD
News / 07.17.17
Study of Indian genetics reveals population bottlenecks similar to those that, in other groups, have yielded key discoveries relevant to prevention, treatment of diseaseRead more
News / 07.5.17
A new study shows that cancer cells across multiple lineages can adopt the same therapy-resistant cell state, enabling broad resistance to targeted therapies. However, the resulting cell circuitry also results in a vulnerability that can be exploited to induce a form of cell death called ferroptosis.Read more
Profiles / 07.19.17
Four years ago, Tom and Karen Hamilton received a devastating diagnosis. A doctor informed them that their nine-year-old daughter had a rare and progressive disorder known as Friedreich’s ataxia (FA...Read more
News / 07.10.17
If other key patent holders join, pool would expand access and streamline non-exclusive licensing for commercial useRead more
Blog / 07.6.17
The successful early-stage clinical trial of a personalized cancer vaccine for melanoma represents the culmination of almost a decade’s collaborative work to overcome challenges large and small.Read more
News / 06.28.17
Fine-mapping parts of the genome linked to inflammatory bowel disease helps international team get closer to the genetic culprits behind the conditionRead more
News / 05.18.17
Sequencing prostate tumors from African-American men reveals a novel tumor suppressor geneRead more
News / 06.26.17
New position recognizes essential role of professional scientists in stewarding the Broad communityRead more
News / 06.21.17
New work points to inflammation as key player in heart disease; suggests future potential for screening to reduce riskRead more
News / 05.24.17
GATK4 brings significant speed optimizations, new tools, and open source licensing RELATED: Open source: Foundation for the future | GATK user support forumRead more
News / 05.24.17
Analysis of the largest collection of Zika genomes to date reveals the trajectory and evolution of the virus as it spread throughout the Americas, with implications for future surveillance efforts.Read more
Spotlight / 06.20.17
Are you a member of a Broad-affiliated institution? Are you interested become more engaged with the Broad's scientific work and community?Read more
Spotlight / 06.22.17
Midsummer Nights' Science is an annual lecture series that explores key advances in genomics and medicine. This lecture series is held each summer, and is free and open to the general public...Read more
Events / 06.28.17
Models, Inference & Algorithms (MIA) is a Broad initiative to support learning and collaboration across the interface of biology and mathematics / statistics / machine learning / computer science...Read more